John Broad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
John Broad has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Gareth John Sanger
Blizard Institute, Faculty of Medicine and Dentistry Queen Mary University of London London UK
3 shared publications - Charles H. Knowles
Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London E1 4NS, UK
2 shared publications Gareth J. Sanger
2 shared publications- George Boundouki
Breast Surgery, Royal Hallamshire Hospital, Sheffield, UK
2 shared publications - Agnieszka Góralczyk
Department of Occupational Medicine, Medical University of Lublin, 20-090 Lublin, Poland
1 shared publication - Aidan Seeley
Swanesa University Medical School, Singleton Park Campus, Swansea SA2 8PP, UK; Sums3d, Swansea University Medical School, Singleton Park Campus, Swansea SA2 8PP, UK
1 shared publication
Latest Publications
- Open Access
- 21 October 2026
- Published by Wiley in Pharmacology Research & Perspectives
- Vol. 14 (6)
What Does the Pharmaceutical Industry Look for in Pharmacology Graduates? A Thematic Analysis of Semi‐Structured Interviews With Pharmaceutical Industry Employees on Their Perceptions of Pharmacology Graduates
The pharmaceutical industry is a major employer of graduates from pharmacology BSc and MSc programs. Understanding its expectations of graduates is therefore important for pharmacology educators. To explore this, interviews were conducted with pharmaceutical industry employees to understand their views on graduate colleagues. Eight semi‐structured interviews were conducted with employees of the UK pharmaceutical sector, identified by convenience sampling. The transcripts of the interviews were coded, and the resulting 117 codes were used to generate three themes and nine sub‐themes. The first theme concerned how academia should prepare students for industry careers. The subthemes included what academia should focus on in their courses; differences identified by interviewees between industry and academia; educating students about the reality of careers in industry; and highlighting career options outside of academia via industrial placements. The second theme concerned the graduate attributes desired by industry, with the subthemes of knowledge, skills, behaviors and attitudes. Finally, the third theme concerned the behaviors and attributes students should develop to be successful in industry. These findings provide insight into graduate preparation for the workplace and may inform pharmacology program design. Exploring the views of employees in other career destinations of pharmacology graduates would be valuable. Limitations include convenience sampling, the limited number of participants, and the potential for interviewer bias.
- 21 October 2026
- Published by Wiley in Pharmacology Research & Perspectives
- Vol. 14 (6)
Open AccessWhat Does the Pharmaceutical Industry Look for in Pharmacology Graduates? A Thematic Analysis of Semi‐Structured Interviews With Pharmaceutical Industry Employees on Their Perceptions of Pharmacology Graduates
The pharmaceutical industry is a major employer of graduates from pharmacology BSc and MSc programs. Understanding its expectations of graduates is therefore important for pharmacology educators. To explore this, interviews were conducted with pharmaceutical industry employees to understand their views on graduate colleagues. Eight semi‐structured interviews were conducted with employees of the UK pharmaceutical sector, identified by convenience sampling. The transcripts of the interviews were coded, and the resulting 117 codes were used to generate three themes and nine sub‐themes. The first theme concerned how academia should prepare students for industry careers. The subthemes included what academia should focus on in their courses; differences identified by interviewees between industry and academia; educating students about the reality of careers in industry; and highlighting career options outside of academia via industrial placements. The second theme concerned the graduate attributes desired by industry, with the subthemes of knowledge, skills, behaviors and attitudes. Finally, the third theme concerned the behaviors and attributes students should develop to be successful in industry. These findings provide insight into graduate preparation for the workplace and may inform pharmacology program design. Exploring the views of employees in other career destinations of pharmacology graduates would be valuable. Limitations include convenience sampling, the limited number of participants, and the potential for interviewer bias.
- Open Access
- 18 June 2026
- Published by Wiley in Pharmacology Research & Perspectives
- Vol. 14 (4) , e70291
Student and Graduate Perceptions of Their Development of the Core Attitudes From the British Pharmacological Society's Undergraduate Pharmacology Curriculum
The British Pharmacological Society's undergraduate core curriculum defines 18 core attitudes that pharmacology students should have after the completion of their degree. While the attainment of pharmacological knowledge and application of skills have previously been evaluated, assessment of core attitudes has not previously been reported. This study investigated student and graduate perceptions of their development of the core attitudes following the introduction of the core curriculum. An anonymous online survey was distributed via members of the British Pharmacological Society's Educator Network to current undergraduate pharmacology students and graduates, who were asked to rate their agreement, using a five‐point Likert scale, with statements indicating whether their degree contributed to the development of each of the 18 core attitudes. A total of 118 students and 70 graduates participated. Both groups reported predominantly positive perceptions across all attitudes, ranging from 54.2%–93.2% (64/118–110/118) in students and 57.1%–91.4% (40/70–64/70) in graduates, with the strongest agreement observed for appreciation of the societal relevance of pharmacology. Although overall response distributions differed significantly between students and graduates, differences were limited to a small number of statements, with graduates showing greater variability and more polarized responses. The highest proportion of negative responses in both groups related to identifying employment opportunities and pursuing career goals. Collectively, these findings indicate that pharmacology programmes are largely effective in fostering core attitudes, while highlighting opportunities for educators to reflect on and further strengthen career development and professional preparation within undergraduate curricula.
- 18 June 2026
- Published by Wiley in Pharmacology Research & Perspectives
- Vol. 14 (4) , e70291
Open AccessStudent and Graduate Perceptions of Their Development of the Core Attitudes From the British Pharmacological Society's Undergraduate Pharmacology Curriculum
The British Pharmacological Society's undergraduate core curriculum defines 18 core attitudes that pharmacology students should have after the completion of their degree. While the attainment of pharmacological knowledge and application of skills have previously been evaluated, assessment of core attitudes has not previously been reported. This study investigated student and graduate perceptions of their development of the core attitudes following the introduction of the core curriculum. An anonymous online survey was distributed via members of the British Pharmacological Society's Educator Network to current undergraduate pharmacology students and graduates, who were asked to rate their agreement, using a five‐point Likert scale, with statements indicating whether their degree contributed to the development of each of the 18 core attitudes. A total of 118 students and 70 graduates participated. Both groups reported predominantly positive perceptions across all attitudes, ranging from 54.2%–93.2% (64/118–110/118) in students and 57.1%–91.4% (40/70–64/70) in graduates, with the strongest agreement observed for appreciation of the societal relevance of pharmacology. Although overall response distributions differed significantly between students and graduates, differences were limited to a small number of statements, with graduates showing greater variability and more polarized responses. The highest proportion of negative responses in both groups related to identifying employment opportunities and pursuing career goals. Collectively, these findings indicate that pharmacology programmes are largely effective in fostering core attitudes, while highlighting opportunities for educators to reflect on and further strengthen career development and professional preparation within undergraduate curricula.
- Open Access
- 25 July 2025
- Published by Wiley in Pharmacology Research & Perspectives
- Vol. 13 (4) , e70136
Interrogating the Perceptions of Undergraduate Pharmacology Teaching on an MBBS Programme at a UK Medical School
Pharmacology education at medical schools in the UK aims to give newly qualified doctors the ability to apply foundational knowledge of pharmacology and to be able to prescribe drugs safely. This study aimed to assess a current pharmacology curriculum and understand the perspectives of both students and educators around pharmacology teaching. Employing a mixed‐methods approach, the research utilized documentation analysis, focus groups, semi‐structured interviews, and online questionnaires with students, educators and senior academic tutors. The analysis of the current curriculum revealed that 1069 drugs or drug classes were introduced to students in their first 2 years of study of drugs and drug classes. Students reported feeling overwhelmed with the number of drugs they were expected to learn. They suggested increasing contextual learning experiences and more practical prescribing experience. Students emphasized the need for greater visibility of pharmacology teaching. Students and educators identified challenges in integrating pharmacology effectively, which contributed to knowledge gaps. Disparities between students' perceptions of pharmacology education and educators' confidence in its delivery were found. These findings suggest the need to address the number of drugs introduced to students in their first 2 years of study. Recommendations include reducing the number of drugs or drug classes introduced to students, highlighting important drugs or classes, enhancing the visibility of pharmacology in the curriculum, and educating and supporting staff when preparing teaching sessions that involve pharmacology. These measures may address students' feelings of being overwhelmed by pharmacology, aligning with the aim of developing medical students into safe prescribers following graduation.
- 25 July 2025
- Published by Wiley in Pharmacology Research & Perspectives
- Vol. 13 (4) , e70136
Open AccessInterrogating the Perceptions of Undergraduate Pharmacology Teaching on an MBBS Programme at a UK Medical School
Pharmacology education at medical schools in the UK aims to give newly qualified doctors the ability to apply foundational knowledge of pharmacology and to be able to prescribe drugs safely. This study aimed to assess a current pharmacology curriculum and understand the perspectives of both students and educators around pharmacology teaching. Employing a mixed‐methods approach, the research utilized documentation analysis, focus groups, semi‐structured interviews, and online questionnaires with students, educators and senior academic tutors. The analysis of the current curriculum revealed that 1069 drugs or drug classes were introduced to students in their first 2 years of study of drugs and drug classes. Students reported feeling overwhelmed with the number of drugs they were expected to learn. They suggested increasing contextual learning experiences and more practical prescribing experience. Students emphasized the need for greater visibility of pharmacology teaching. Students and educators identified challenges in integrating pharmacology effectively, which contributed to knowledge gaps. Disparities between students' perceptions of pharmacology education and educators' confidence in its delivery were found. These findings suggest the need to address the number of drugs introduced to students in their first 2 years of study. Recommendations include reducing the number of drugs or drug classes introduced to students, highlighting important drugs or classes, enhancing the visibility of pharmacology in the curriculum, and educating and supporting staff when preparing teaching sessions that involve pharmacology. These measures may address students' feelings of being overwhelmed by pharmacology, aligning with the aim of developing medical students into safe prescribers following graduation.
- Open Access
- 31 August 2024
- Published by Wiley in United European Gastroenterology Journal
- Vol. 12 (10) , 1417-1428
The impact of long‐course chemoradiotherapy on the myenteric plexus, neuromuscular functions and responses to prokinetic drugs in the human rectum
Background & Aims: The long‐term effects of chemoradiotherapy on human rectum are poorly understood. The aims were to investigate changes in inflammatory status, myenteric neuron numbers/phenotype, neuromuscular functions and prokinetic drug efficacy. Methods: Macroscopically normal proximal‐to‐mid rectum was obtained from 21 patients undergoing surgery for bowel cancer, 98 days (range: 63–350) after concurrent capecitabine and pelvic radiotherapy, and 19 patients without chemoradiotherapy. Inflammatory status was measured by H&E, CD45 staining and qPCR. Myenteric neurons were examined by immunohistochemistry. Neuromuscular functions and drug efficacy were studied using exogenous agents and electrical field stimulation (EFS) to activate intrinsic nerves. Results: Inflammation was not detected. Numbers of myenteric ganglia/neurons were unchanged (11.7 ± 2.4 vs. 10.3 ± 2.2 neurons/mm myenteric plexus with/without chemoradiotherapy) as were the numbers of cholinergic/nitrergic neurons. EFS stimulated cholinergic and nitrergic neurons so the contractile response of the muscle was the sum of both but dominated by cholinergic (causing contraction) or less often, nitrergic activity (relaxation), followed, after termination of EFS, by neuronally mediated contraction. Inhibition of nitric oxide synthase (by L‐NAME 300 μM) more clearly defined EFS‐evoked contractions. The 5‐HT 4 agonist prucalopride 10 μM and the cholinesterase inhibitor donepezil 1 µM, respectively increased and greatly increased the composite contractile response to EFS (measured as ‘area‐under‐the curve’) and the contractions isolated by L‐NAME (respectively, by 22 ± 14% and 334 ± 87%; n = 11/8). After chemoradiotherapy, nitrergic‐mediated muscle relaxations occurred more often during EFS (in 29.8 ± 6.1% preparations vs. 12.6 ± 5.1% without chemoradiotherapy, n = 21/18). With L‐NAME, the ability of prucalopride to facilitate EFS‐evoked contraction was lost and that of donepezil approximately halved (contractions increased by 132 ± 36%; n = 8). Conclusions: Several months after chemoradiotherapy, the rectum was not inflamed and myenteric neuron numbers/phenotype unchanged. However, nitrergic activity was increased relative to cholinergic activity, and prokinetic‐like drug activity was lost or greatly reduced. Thus, chemoradiotherapy causes long‐term changes in neuromuscular functions and markedly reduces the efficacy of drugs for treating constipation.
- 31 August 2024
- Published by Wiley in United European Gastroenterology Journal
- Vol. 12 (10) , 1417-1428
Open AccessThe impact of long‐course chemoradiotherapy on the myenteric plexus, neuromuscular functions and responses to prokinetic drugs in the human rectum
Background & Aims: The long‐term effects of chemoradiotherapy on human rectum are poorly understood. The aims were to investigate changes in inflammatory status, myenteric neuron numbers/phenotype, neuromuscular functions and prokinetic drug efficacy. Methods: Macroscopically normal proximal‐to‐mid rectum was obtained from 21 patients undergoing surgery for bowel cancer, 98 days (range: 63–350) after concurrent capecitabine and pelvic radiotherapy, and 19 patients without chemoradiotherapy. Inflammatory status was measured by H&E, CD45 staining and qPCR. Myenteric neurons were examined by immunohistochemistry. Neuromuscular functions and drug efficacy were studied using exogenous agents and electrical field stimulation (EFS) to activate intrinsic nerves. Results: Inflammation was not detected. Numbers of myenteric ganglia/neurons were unchanged (11.7 ± 2.4 vs. 10.3 ± 2.2 neurons/mm myenteric plexus with/without chemoradiotherapy) as were the numbers of cholinergic/nitrergic neurons. EFS stimulated cholinergic and nitrergic neurons so the contractile response of the muscle was the sum of both but dominated by cholinergic (causing contraction) or less often, nitrergic activity (relaxation), followed, after termination of EFS, by neuronally mediated contraction. Inhibition of nitric oxide synthase (by L‐NAME 300 μM) more clearly defined EFS‐evoked contractions. The 5‐HT 4 agonist prucalopride 10 μM and the cholinesterase inhibitor donepezil 1 µM, respectively increased and greatly increased the composite contractile response to EFS (measured as ‘area‐under‐the curve’) and the contractions isolated by L‐NAME (respectively, by 22 ± 14% and 334 ± 87%; n = 11/8). After chemoradiotherapy, nitrergic‐mediated muscle relaxations occurred more often during EFS (in 29.8 ± 6.1% preparations vs. 12.6 ± 5.1% without chemoradiotherapy, n = 21/18). With L‐NAME, the ability of prucalopride to facilitate EFS‐evoked contraction was lost and that of donepezil approximately halved (contractions increased by 132 ± 36%; n = 8). Conclusions: Several months after chemoradiotherapy, the rectum was not inflamed and myenteric neuron numbers/phenotype unchanged. However, nitrergic activity was increased relative to cholinergic activity, and prokinetic‐like drug activity was lost or greatly reduced. Thus, chemoradiotherapy causes long‐term changes in neuromuscular functions and markedly reduces the efficacy of drugs for treating constipation.
- Open Access
- 15 January 2024
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 39 (4) , 649-657
Prevalence and disease burden of gastroparesis in Asia
Gastroparesis is a gastrointestinal disorder characterized by significant prolongation of gastric emptying time caused by impaired motility of the stomach. Its estimated prevalence is 24.2 per 100 000 people. However, the prevalence of gastroparesis in Asian countries is unknown due to a limited number of epidemiological studies and significant phenotypic variability of the Asian population in these studies. Analysis of previous research on gastroparesis and functional bowel disorders reveals the possibility of an increased prevalence among Asian individuals. A comparison of ethnic constituents between the recent United Kingdom gastroparesis study and its mother database has demonstrated a higher prevalence of gastroparesis among British Asian patients when compared with British Caucasian patients. An estimated gastroparesis prevalence in the Asian population can be calculated by identifying the individuals who are likely to demonstrate a delayed gastric emptying from all diagnosed functional dyspepsia patients. We suggest that gastroparesis tends to be underdiagnosed in Asians due to a lack of studies on gastroparesis in the Asian continent, a lack of knowledge among practitioners, and poor availability of scintigraphy testing as well as limited therapeutic options for this disease. Given the high probability of Asian predominance in gastroparesis and its disease impact on quality of life, epidemiological research focusing on the Asian population is required.
- 15 January 2024
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 39 (4) , 649-657
Open AccessPrevalence and disease burden of gastroparesis in Asia
Gastroparesis is a gastrointestinal disorder characterized by significant prolongation of gastric emptying time caused by impaired motility of the stomach. Its estimated prevalence is 24.2 per 100 000 people. However, the prevalence of gastroparesis in Asian countries is unknown due to a limited number of epidemiological studies and significant phenotypic variability of the Asian population in these studies. Analysis of previous research on gastroparesis and functional bowel disorders reveals the possibility of an increased prevalence among Asian individuals. A comparison of ethnic constituents between the recent United Kingdom gastroparesis study and its mother database has demonstrated a higher prevalence of gastroparesis among British Asian patients when compared with British Caucasian patients. An estimated gastroparesis prevalence in the Asian population can be calculated by identifying the individuals who are likely to demonstrate a delayed gastric emptying from all diagnosed functional dyspepsia patients. We suggest that gastroparesis tends to be underdiagnosed in Asians due to a lack of studies on gastroparesis in the Asian continent, a lack of knowledge among practitioners, and poor availability of scintigraphy testing as well as limited therapeutic options for this disease. Given the high probability of Asian predominance in gastroparesis and its disease impact on quality of life, epidemiological research focusing on the Asian population is required.
- 1 April 2015
- Published by Elsevier in European Journal of Pharmacology
- Vol. 752, 34-39
Analysis of the ghrelin receptor-independent vascular actions of ulimorelin
- 1 April 2015
- Published by Elsevier in European Journal of Pharmacology
- Vol. 752, 34-39
Analysis of the ghrelin receptor-independent vascular actions of ulimorelin
- 20 April 2014
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 26 (6) , 851-861
Drugs acting at 5‐HT4, D2, motilin, and ghrelin receptors differ markedly in how they affect neuromuscular functions in human isolated stomach
Progress in identifying safer, effective drugs to increase gastric emptying is impeded by failed clinical trials. One potential reason for failure is lack of translation from animal models to the human condition. To make progress, the actions of existing drugs and new therapeutic candidates need to be understood in human isolated stomach. Neuromuscular activities were evoked in human gastric antrum circular muscle by electrical field stimulation (EFS), defined phenotypically using pharmacological tools. EFS evoked cholinergically mediated contractions, attenuated by simultaneous nitrergic activation. The 5-HT4 receptor agonist/D2 antagonist metoclopramide and the selective 5-HT4 agonist prucalopride, facilitated contractions in the absence (respectively, Emax 95 ± 29% and 42 ± 9%, n = 3-6 each concentration) and presence (139 ± 38%, 55 ± 13%, n = 3-5) of the NO synthase inhibitor L-NAME, without affecting submaximal contractions to carbachol; the 5-HT4 antagonist SB204070 prevented facilitation by metoclopramide 100 μM (respectively, -5 (range -26 to 34) and 167 (12-1327)% in presence and absence; n = 5-6). The selective motilin receptor agonist camicinal provided considerably greater facilitation (478 (12-2080)% at 30 μM, n = 8). Domperidone (0.001-100 μM; n = 3-6) and acylated or des-acylated ghrelin (1-300 nM; n = 2-4) had no consistent activity, even with protease inhibitors. 5-HT4 receptor agonists show different efficacies. Motilin receptor activation has greater potential to increase gastric emptying, whereas ghrelin and D2 receptor antagonism have no direct activity. Drugs stimulating human gastric motility directly can act regardless of disease mechanisms, whereas drugs without direct activity but an ability to block nausea/vomiting may be effective only if these symptoms exist.
- 20 April 2014
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 26 (6) , 851-861
Drugs acting at 5‐HT4, D2, motilin, and ghrelin receptors differ markedly in how they affect neuromuscular functions in human isolated stomach
Progress in identifying safer, effective drugs to increase gastric emptying is impeded by failed clinical trials. One potential reason for failure is lack of translation from animal models to the human condition. To make progress, the actions of existing drugs and new therapeutic candidates need to be understood in human isolated stomach. Neuromuscular activities were evoked in human gastric antrum circular muscle by electrical field stimulation (EFS), defined phenotypically using pharmacological tools. EFS evoked cholinergically mediated contractions, attenuated by simultaneous nitrergic activation. The 5-HT4 receptor agonist/D2 antagonist metoclopramide and the selective 5-HT4 agonist prucalopride, facilitated contractions in the absence (respectively, Emax 95 ± 29% and 42 ± 9%, n = 3-6 each concentration) and presence (139 ± 38%, 55 ± 13%, n = 3-5) of the NO synthase inhibitor L-NAME, without affecting submaximal contractions to carbachol; the 5-HT4 antagonist SB204070 prevented facilitation by metoclopramide 100 μM (respectively, -5 (range -26 to 34) and 167 (12-1327)% in presence and absence; n = 5-6). The selective motilin receptor agonist camicinal provided considerably greater facilitation (478 (12-2080)% at 30 μM, n = 8). Domperidone (0.001-100 μM; n = 3-6) and acylated or des-acylated ghrelin (1-300 nM; n = 2-4) had no consistent activity, even with protease inhibitors. 5-HT4 receptor agonists show different efficacies. Motilin receptor activation has greater potential to increase gastric emptying, whereas ghrelin and D2 receptor antagonism have no direct activity. Drugs stimulating human gastric motility directly can act regardless of disease mechanisms, whereas drugs without direct activity but an ability to block nausea/vomiting may be effective only if these symptoms exist.
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Serum but Not IgG From Patients With Chagas' Disease Relax Naive Human Colon Muscle Without Directly Interfering With Motor Nerve Functions
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Serum but Not IgG From Patients With Chagas' Disease Relax Naive Human Colon Muscle Without Directly Interfering With Motor Nerve Functions
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Regionally-Dependent Responses to Both Nerve Stimulation and to Motilin in Human Isolated Esophagus, Stomach, Small and Large Intestine
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Regionally-Dependent Responses to Both Nerve Stimulation and to Motilin in Human Isolated Esophagus, Stomach, Small and Large Intestine